USD $2703.24
AFINITOR is a prescription medication used to treat various types of cancer and tumors, including certain types of breast cancer, kidney cancer, and pancreatic neuroendocrine tumors. It works by targeting specific proteins in cancer cells, thereby inhibiting their growth and spread.
AFINITOR belongs to a class of drugs known as mTOR inhibitors. It works by blocking the mTOR protein, which plays a critical role in cell growth, proliferation, and survival. By inhibiting this protein, AFINITOR can effectively slow down or stop the growth of cancer cells.
AFINITOR is suitable for patients with advanced hormone receptor-positive, HER2-negative breast cancer, in combination with other therapies. It is also used for patients with advanced renal cell carcinoma, subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC), and certain types of pancreatic neuroendocrine tumors.
Common side effects of AFINITOR include mouth ulcers, infections, rash, diarrhea, fatigue, and nausea. Patients may also experience changes in blood cell counts and liver function tests. It is important to discuss potential side effects with a healthcare provider before starting treatment.
AFINITOR is typically taken once daily, with or without food. It is important to take the medication at the same time each day and follow the healthcare provider’s instructions carefully. Patients should not alter the dosage without consulting their doctor.
Patients should inform their healthcare provider of any existing medical conditions, including liver problems, diabetes, or infections. AFINITOR may interact with other medications, so it is crucial to inform the healthcare provider of all medications being taken. Regular monitoring of blood counts and liver function is recommended during treatment.
If a dose of AFINITOR is missed, it should be taken as soon as remembered unless it is close to the time of the next dose. In such cases, the missed dose should be skipped, and the regular dosing schedule should be continued. Doubling up on doses is not advised.
AFINITOR is not recommended for use during pregnancy due to potential harm to the unborn baby. Women of childbearing potential should use effective contraception during treatment. It is also advised not to breastfeed while taking AFINITOR, as it may pass into breast milk and harm the nursing infant.
Health Guides